REQUEST A DEMO
Total
USD $0.00
Search more companies

Ipsen Pharma Hungary Kft. (Hungary)

Main Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers
Full name: Ipsen Pharma Hungary Kft. Profile Updated: April 21, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Hungarian Download a sample report

Ipsen Pharma Hungary Kft. is an enterprise in Hungary, with the main office in Budapest. It operates in the Other Miscellaneous Nondurable Goods Merchant Wholesalers sector. The company was established on May 31, 2018. 10 (2024) employees currently work for Ipsen Pharma Hungary Kft.. The latest financial highlights indicate a net sales revenue increase of 7.37% in 2025. There was a total growth of 10.57% in Ipsen Pharma Hungary Kft.’s total assets over the same period. In 2025, Ipsen Pharma Hungary Kft.’s net profit margin increased by 2.1%.

Headquarters
Vaci ut 33. 9. emelet
Budapest; Budapest; Postal Code: 1134

Contact Details: Purchase the Ipsen Pharma Hungary Kft. report to view the information.

Website: http://www.ipsen.com

Basic Information
Total Employees:
Purchase the Ipsen Pharma Hungary Kft. report to view the information.
Registered Capital:
Purchase the Ipsen Pharma Hungary Kft. report to view the information.
Financial Auditors:
Purchase the Ipsen Pharma Hungary Kft. report to view the information.
Incorporation Date:
May 31, 2018
Key Executives
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Ipsen Pharma Hungary Kft. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
7.37%
Total Operating Revenue
4.76%
Operating Profit
90.39%
EBITDA
84.62%
Net Profit/Loss for the Period
89.3%
Total Assets
10.57%
Total Equity
58.31%
Operating Profit Margin
2.37%
Net Profit Margin
2.1%
Return on Equity (ROE)
6.03%
Quick Ratio
0.3%
Cash Ratio
0.02%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?